Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)
In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...
Reuters23h
Novo Nordisk A/S
Halozyme makes 2 billion euro buyout offer for drug developer Evotec November 14, 2024 Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends ...
pharmaphorum23h
Oral insulin could still be a reality, says Novo Nordisk
Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market . But the company has just presented early stage data showing the formulation to ...
Analysis-RFK Jr vow to purge FDA sets up collision with Big Pharma
WASHINGTON/NEW YORK (Reuters) - Robert F. Kennedy Jr. vowed to purge the U.S. Food and Drug Administration shortly before being chosen as President-elect Donald Trump's nominee for health secretary.
Bloomberg L.P.11h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...